Lanean...
Targeting the HER/EGFR/ErbB Family to Prevent Breast Cancer
Preventing breast cancer is possible with selective estrogen-receptor (ER) modulators and aromatase inhibitors, which reduce the risk of invasive disease by up to 65% [up to 73% for estrogen receptor (ER)-positive and no effect for ER-negative cancer] and the risk of pre-invasive disease [ductal car...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3171200/ https://ncbi.nlm.nih.gov/pubmed/21816844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-11-0334 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|